Prostate cancer relies on genetic “switches”, called enhancers, that can turn on tumor-promoting genes. Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B ...

Metastatic castration-resistant prostate cancer (mCRPC) is driven by molecular and genetic alterations in multiple signaling pathways and usually progresses despite initial response to androgen ...

Please provide your email address to receive an email when new articles are posted on . Adding niraparib to abiraterone acetate and prednisone lowered risk for cancer growth by 37% among certain ...

Add Yahoo as a preferred source to see more of our stories on Google. A major international trial finds that adding niraparib to standard prostate cancer therapy delays disease progression. (CREDIT: ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers found that specially designed supplements of vegetables and probiotics appeared to slow progression of an indicator of ...

New Delhi: Certain drugs used to treat type 2 diabetes can also be used to treat prostate cancer, according to a study. Researchers from the Medical University of Vienna in Austria identified ...

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes. Researchers at the University of Michigan Health Rogel Cancer Center have discovered histone H2B ...